7759 logo

Sunhawk Vision Biotech, Inc. Stock Price

TPEX:7759 Community·NT$2.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

7759 Share Price Performance

NT$0
-77.00 (-100.00%)
NT$0
-77.00 (-100.00%)
Price NT$0

7759 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with low risk.

3 Risks
0 Rewards

Sunhawk Vision Biotech, Inc. Key Details

NT$0

Revenue

NT$0

Cost of Revenue

NT$0

Gross Profit

NT$172.4m

Other Expenses

-NT$172.4m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-2.46
0%
0%
0%
View Full Analysis

About 7759

Founded
2019
Employees
n/a
CEO
Suh-Hang Juo
WebsiteView website
sunhawkvision.com

Sunhawk Vision Biotech, Inc., a drug development company, engages in the research and development of children's myopia eye drops, dry eye drops, and other nucleic acid new drugs for the treatment of ocular surface diseases in Taiwan. The company develops SHJ002 eye drops, which have completed a Phase 2 clinical trial for the treatment of dry eye disease in adult patients and corneal erosion in patients with Sjogren’s syndrome, as well as in a Phase 2 clinical trial for myopia control in young children. Sunhawk Vision Biotech, Inc. was founded in 2019 and is based in Taipei, Taiwan.

Recent 7759 News & Updates

Recent updates

No updates